2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2021 | The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2021 | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study | DIGESTIVE DISEASES AND SCIENCES |
2021 | Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2021 | Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals | JOURNAL OF VIRAL HEPATITIS |
2021 | 소화기내과 전임의 수련에 대한 COVID-19의 영향
| Korean Journal of Gastroenterology |
2021 | Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma
| GUT AND LIVER |
2021 | Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2021 | The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B | HEPATOLOGY RESEARCH |
2021 | Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
| Journal of Liver Cancer(대한간암학회지) |
2021 | A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
| Journal of Liver Cancer(대한간암학회지) |
2021 | Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma | CANCER INVESTIGATION |
2021 | Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B | EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2021 | Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2021 | Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
| CURRENT ONCOLOGY |
2021 | Letter to the Editor: Re: Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection | HEPATOLOGY |
2021 | The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2021 | Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
| GUT AND LIVER |
2021 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2021 | Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir | JOURNAL OF VIRAL HEPATITIS |
2021 | Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
2020 | A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy | JOURNAL OF VIRAL HEPATITIS |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
2020 | Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2020 | The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
| GUT AND LIVER |
2020 | Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
| CANCERS |
2020 | Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B | DIGESTIVE AND LIVER DISEASE |
2020 | Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack | CEREBROVASCULAR DISEASES |
2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
2020 | Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma | JOURNAL OF VIRAL HEPATITIS |
2020 | Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
| CANCERS |
2020 | How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia | LIVER INTERNATIONAL |
2020 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2020 | Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy | JOURNAL OF HEPATOLOGY |
2020 | Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
| GUT AND LIVER |
2020 | Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial Radioembolization | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | Influence of Besifovir Dipivoxil Maleate Combined With L-Carnitine on Hepatic Steatosis in Patients With Chronic Hepatitis B
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2020 | KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2020 | Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis C | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | The HBeAg-Negative "Gray Zone" Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients? Reply | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Reply to: "Comment on - A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in the Republic of Korea" | JOURNAL OF HEPATOLOGY |
2020 | A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |